Acrivon Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $76k | 64k | 1.19 |
| 2025-03-31 | $226k | 111k | 2.03 |
| 2024-12-31 | $685k | 114k | 6.02 |
| 2024-09-30 | $814k | 116k | 7.00 |
| 2024-06-30 | $835k | 144k | 5.80 |
| 2024-03-31 | $553k | 77k | 7.15 |
| 2023-12-31 | $337k | 69k | 4.92 |
| 2023-09-30 | $647k | 68k | 9.56 |
| 2023-06-30 | $790k | 61k | 12.96 |
| 2023-03-31 | $739k | 58k | 12.69 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management